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ABSTRACT The keystone oral pathogen Porphyromonas gingivalis is associated with
severe periodontitis. Intriguingly, this bacterium is known to secrete large amounts
of an enzyme that converts peptidylarginine into citrulline residues. The present
study was aimed at identifying possible functions of this citrullinating enzyme,
named Porphyromonas peptidylarginine deiminase (PPAD), in the periodontal envi-
ronment. The results show that PPAD is detectable in the gingiva of patients with
periodontitis, and that it literally neutralizes human innate immune defenses at
three distinct levels, namely bacterial phagocytosis, capture in neutrophil extracellu-
lar traps (NETs), and killing by the lysozyme-derived cationic antimicrobial peptide
LP9. As shown by mass spectrometry, exposure of neutrophils to PPAD-proﬁcient
bacteria reduces the levels of neutrophil proteins involved in phagocytosis and the
bactericidal histone H2. Further, PPAD is shown to citrullinate the histone H3,
thereby facilitating the bacterial escape from NETs. Last, PPAD is shown to citrulli-
nate LP9, thereby restricting its antimicrobial activity. The importance of PPAD for
immune evasion is corroborated in the infection model Galleria mellonella, which
only possesses an innate immune system. Together, the present observations show
that PPAD-catalyzed protein citrullination defuses innate immune responses in the
oral cavity, and that the citrullinating enzyme of P. gingivalis represents a new type
of bacterial immune evasion factor.
IMPORTANCE Bacterial pathogens do not only succeed in breaking the barriers that
protect humans from infection, but they also manage to evade insults from the hu-
man immune system. The importance of the present study resides in the fact that
protein citrullination is shown to represent a new bacterial mechanism for immune
evasion. In particular, the oral pathogen P. gingivalis employs this mechanism to de-
fuse innate immune responses by secreting a protein-citrullinating enzyme. Of note,
this ﬁnding impacts not only the global health problem of periodontitis, but it also
extends to the prevalent autoimmune disease rheumatoid arthritis, which has been
strongly associated with periodontitis, PPAD activity, and loss of tolerance against
citrullinated proteins, such as the histone H3.
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Periodontitis affects around 10% to 15% of the adult population, making it one ofthe most prevalent diseases worldwide (1). It is characterized by chronic inﬂam-
mation of the tissues supporting the teeth and is associated with a dysbiotic oral
microbiome found primarily in the form of bioﬁlms in the periodontal pocket (Fig. 1a).
These conditions trigger an increased tissue inﬁltration by immune cells, mainly neu-
trophils, which play a pivotal role in maintaining periodontal health by employing
diverse and potent bactericidal mechanisms (2, 3). Successful periodontal pathogens,
however, have evolved sophisticated strategies to avoid or subvert neutrophil killing
and to thrive in an inﬂamed environment. In particular, the Gram-negative anaerobe
Porphyromonas gingivalis, which is considered a major etiological agent of periodon-
titis, possesses the ability to dysregulate the homeostasis between oral bioﬁlms and
innate immunity (2, 3). The bacterium secretes large amounts of a unique enzyme, the
P. gingivalis peptidylarginine deiminase (PPAD), which catalyzes the citrullination of
both bacterial and host proteins (4–8). This posttranslational protein modiﬁcation
involves the deimination of positively charged arginine residues into neutral citrulline
residues. Intriguingly, P. gingivalis has not only been implicated in periodontitis but also
in the prevalent autoimmune disease rheumatoid arthritis, which is strongly associated
with periodontitis, PPAD activity, and a loss of tolerance against citrullinated proteins,
such as the histone H3 (2, 9–11). Nonetheless, the biological and clinical relevance of
PPAD for dysbiosis in the oral cavity had so far remained enigmatic. The question raised
in our present study was whether this citrullinating enzyme may literally neutralize
human innate immune defenses in the periodontal environment, thereby serving as a
secreted bacterial immune evasion factor.
RESULTS AND DISCUSSION
PPAD impairs bacterial binding and internalization by neutrophils. To verify the
relevance of PPAD production in inﬂamed periodontal tissue, we performed immuno-
histochemistry using a previously developed PPAD-speciﬁc antibody. As shown in
Fig. 1b, this allowed us to detect the presence of PPAD in gingival tissues of perio-
dontitis patients for the ﬁrst time. This observation enticed us to further investigate the
interaction of P. gingivalis with key host immune cells. In particular, we aimed this
investigation at dissecting potentially pleiotropic functions of PPAD in the evasion of
neutrophil-speciﬁc innate immunity by P. gingivalis W83, previously characterized as
one of the most virulent Porphyromonas strains (12). Challenge with human neutrophils
showed that strain W83 is bound and internalized by these neutrophils (Fig. 2a and b).
Notably, the association and internalization levels observed for a genetically engi-
neered PPAD-deﬁcient P. gingivalismutant were 2- to 3-fold higher than in the parental
W83 strain (Fig. 2b). This is partly related to a higher percentage of the neutrophils
binding and internalizing PPAD-deﬁcient P. gingivalis (Fig. S1a). The addition of PPAD-
containing culture supernatant allowed the PPAD-deﬁcient mutant to evade neutrophil
association and internalization, and signiﬁcant evasion of neutrophil internalization was
even observed upon the addition of puriﬁed recombinant PPAD (Fig. 2c and d). This
shows that PPAD helps P. gingivalis evade destruction by neutrophils, which is a
prerequisite to survive the high neutrophil inﬂux in inﬂamed gingival tissue of perio-
dontitis patients.
We have recently shown that PPAD is secreted in two different forms, either in a
soluble state or bound to excreted outer membrane vesicles (OMVs) (7, 8). As shown
with the recombinant protein, soluble PPAD can limit neutrophil internalization, and
the same effect was observed upon addition of puriﬁed PPAD-containing OMVs to the
PPAD-deﬁcient P. gingivalis (Fig. 2d; see also Fig. S1b and c in the supplemental
material). Moreover, these OMVs even inhibited binding of the PPAD mutant bacteria
by neutrophils (Fig. 2c). Together, these observations imply that both forms of secreted
PPAD, soluble and OMV bound, can serve to protect P. gingivalis against containment
and elimination by human neutrophils. Further, the data suggest that OMV-bound
PPAD could be primarily used by P. gingivalis to evade neutrophil binding, while the
soluble PPAD might be more effective against internalization. However, it is important
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to bear in mind that the recombinant PPAD isolated from Lactococcus lactis, though
soluble and enzymatically active, may lack particular as-yet-unidentiﬁed posttransla-
tional modiﬁcations that are present in the soluble PPAD produced by P. gingivalis.
Such modiﬁcations could impact, for example, the enzyme’s substrate speciﬁcity and
speciﬁc activity. This awaits further experimental veriﬁcation by puriﬁcation of soluble
FIG 1 Detection of PPAD in gingival tissue of a periodontitis patient. (a) Hallmarks of periodontitis, with schematic representation of
bioﬁlm formation and neutrophil recruitment in the periodontal pocket. Note that the periodontal bioﬁlm is polymicrobial, where P.
gingivalis is represented in green and other microorganisms in orange and blue. (b) PPAD detection by immunohistochemistry in
gingival tissues of a periodontitis patient using a PPAD-speciﬁc antibody. Control staining of the same gingival tissues was performed
with the respective rabbit preimmune serum. PPAD staining is observed in gingival tissue primarily around blood vessels (upper
images) or at the epithelium (lower images).
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PPAD from the P. gingivalis W83 growth medium and subsequent functional and
structural characterization.
How could PPAD mediate neutrophil evasion? An attractive hypothesis is that this
involves the so-called gingipains of P. gingivalis, a group of highly proteolytic enzymes,
including the arginine-speciﬁc enzymes RgpA and RgpB (13, 14). We recently reported
that these gingipains are subject to citrullination by PPAD (6). Further, Maekawa et al.
have previously shown that RgpA and RgpB induce Toll-like receptor 2 (TLR2)-C5aR
cross talk, ultimately leading to the inhibition of actin polymerization and consequent
inhibition of phagocytosis (44). We therefore assessed the RgpA and RgpB levels by
Western blotting. As shown in Fig. 3a and S1d, the neutrophils are exposed to lower
levels of RgpA and RgpB in the absence of PPAD. Moreover, the overall proteolytic
activity in the growth medium of PPAD-deﬁcient P. gingivalis is signiﬁcantly reduced, as
shown by a lowered rate of histone H3 protein degradation by PPAD-deﬁcient W83
FIG 2 PPAD impairs bacterial binding and internalization by neutrophils. (a and b) P. gingivalis W83 ΔPPAD is bound and internalized
by neutrophils at a higher rate than wild-type P. gingivalis W83. Microscopic visualization of neutrophils with bound or internalized
P. gingivalis (a) (scale bars  10 m), and the respective association and internalization indices as determined by ﬂow cytometry (b).
(c and d) Rescue of bacterial binding and internalization by neutrophils upon addition of 2.5 g recombinant PPAD (indicated as
PPAD), 16 g PPAD-containing W83 outer membrane vesicles (OMVs), or 100 l PPAD-containing W83 culture supernatant (SN).
Association and internalization indices determined by ﬂow cytometry are shown. (b) Data are means of three biologically independent
samples (neutrophils from three donors), where each infection experiment was carried out four times. (c and d) Data are means of four
replicates of one biological sample (one neutrophil donor). *, P 0.05; **, P 0.01; ***, P 0.001; two-tailed unpaired Student’s t tests.
Data are presented as mean values  standard deviation (SD). a.u., arbitrary units.
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compared to that by the PPAD-proﬁcient strain (Fig. 3b). Overall, in accordance with the
model of Maekawa and colleagues (44), lower levels of RgpA and RgbB at the neutro-
phil surface, as observed for neutrophils infected with PPAD-deﬁcient bacteria, will lead
to less suppression of phagocytosis and therefore enhanced internalization of these
bacteria, as shown in Fig. 2b. The underlying mechanism by which the presence of
PPAD results in increased levels and activity of RgpA and RgpB is likely to be their
previously documented citrullination by PPAD (6), which could confer protection
against possible (self-)cleavage at arginine residues.
Furthermore, to verify the possibility that phagocytosis in neutrophils is decreased
due to lower actin polymerization in the presence of PPAD-proﬁcient bacteria, we
applied a mass spectrometry-based approach. Indeed, the results show that the levels
of the actin assembly-related proteins dynamin-2 (15), actin-related protein 2/3 (16),
and the cell division control protein 42 (17) are decreased when neutrophils are
challenged by wild-type P. gingivalis (Fig. 3c). This is consistent with a role of gingipain
citrullination in the inhibition of actin polymerization and evasion of phagocytosis.
FIG 3 PPAD stabilizes gingipains and modulates the levels of phagocytosis-related proteins. (a) Relative (Rel.) levels
of gingipains (RgpA/RgpB) in infected neutrophils. (b) Time course of histone H3 degradation by P. gingivalis
proteases in the presence or absence of PPAD, as determined by Western blotting (SN, culture supernatant). (c and
d) Quantiﬁcation of signiﬁcant changes in the amounts of phagocytosis-related proteins (c) and the antimicrobial
histone H2B (d) in infected neutrophils, as approximated by mass spectrometry. (a, c, and d) Data are means of
three replicates of one neutrophil donor. **, P  0.01, two-tailed unpaired Student’s t tests. Data are presented as
mean values  SD. *, P  0.05, Fisher’s exact test. Green and red arrows indicate up- or downregulation of 10%
of the respective protein in W83-infected neutrophils. Norm., normalized.
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However, our mass spectrometry analyses provide more clues as to how P. gingivalis
corrupts the neutrophil. For example, the immunoglobulin  constant protein is not
detectable in neutrophils infected with wild-type P. gingivalis, while this protein is
identiﬁed in neutrophils infected with the PPAD mutant (Fig. 3c). This implies a role of
PPAD in inhibiting opsonization of the bacteria, as immunoglobulins are important in
opsonization, which is the ﬁrst step of phagocytosis. Altogether, a challenge with
wild-type P. gingivalis leads to altered levels of 17 phagocytosis-related proteins
compared to the PPAD mutant (Table S1). In particular, the levels of the integrins -M
and -2, involved in actin polymerization (18), are reduced (Fig. 3c). These integrins play
also crucial roles in cell signaling, neutrophil adhesion to endothelial cells, and granule
exocytosis for releasing bactericidal toxins into the intracellular milieu (19). In fact, once
a bacterial prey is internalized by neutrophils, several granule and cytosolic proteins
facilitate its efﬁcient destruction. Among these, the neutrophil cytosolic factor 4 (NCF4/
p40phox) is involved in the oxidative burst that serves to kill internalized bacteria (20).
Indeed, the NCF4 levels are also substantially lower when neutrophils are challenged
with wild-type P. gingivalis than with PPAD-deﬁcient bacteria (Fig. 3c). Last, the bacte-
ricidal histone H2B (21) is present in smaller amounts when neutrophils are exposed to
PPAD-proﬁcient P. gingivalis (Fig. 3d). Altogether, these ﬁndings show that P. gingivalis
needs PPAD to escape internalization and subsequent elimination by neutrophils.
Further, our results correlate the increased phagocytosis in the absence of PPAD to
reduced levels of gingipains and a restricted impact of PPAD-deﬁcient P. gingivalis on
neutrophil proteins needed for phagocytosis.
PPAD citrullinates histone H3 and helps evade NETs. Neutrophils can also
capture bacteria with neutrophil extracellular traps (NETs), which are web-like struc-
tures mainly consisting of decondensed chromatin and bactericidal proteins (22, 23).
Recent studies have shown that NETs are abundantly produced in periodontitis (24, 25).
During the process of NET activation and release (known as NETosis), DNA-bound
histones are citrullinated by the human peptidylarginine deiminases, leading to a
change in charge and decondensation of the DNA (26). Of note, histones are known to
have different roles in NET formation. On the one hand, the positive charge of histones
is needed for their bactericidal effects. On the other hand, Li and colleagues have
shown that citrullination of histone H3 by the human peptidylarginine deiminase 4
(PAD4) is essential for bacterial killing in NETs (27). The process of NETosis can be
artiﬁcially induced by the addition of phorbol myristate acetate (PMA), as shown in
Fig. 4a and b (see also Fig. S2). We exposed PPAD-proﬁcient and PPAD-deﬁcient P.
gingivalis to neutrophils undergoing NETosis and observed higher NETosis in both
infection situations than in the uninfected PMA-activated neutrophils. However, a
greater number of intact neutrophil nuclei were noticed for PPAD-proﬁcient bacteria
than for the PPAD-deﬁcient bacteria (Fig. 4c and d). This indicates that PPAD activity
can impair the bacteria-induced NETosis. Consistent with this view, higher numbers of
PPAD-deﬁcient bacteria were observed to be trapped in NETs (Fig. 4c and d) and
eliminated upon capture (Fig. 4e). The exact mechanisms by which PPAD could
interfere with NET formation are currently unknown and should be a topic of future
investigations. A possible explanation could be that the higher levels of secreted
protease activity produced by the PPAD-proﬁcient bacteria have a negative impact on
the NET formation, for example, by degrading certain human proteins needed for DNA
decondensation.
Histones are critical actors in capture and killing of bacteria in the NETs, and
arginine-rich histones especially directly disrupt the bacterial cell membrane by virtue
of their positive charge (21). We therefore inspected histone H3 citrullination in
neutrophils undergoing NETosis, which revealed a strong PPAD-dependent citrullina-
tion of this antibacterial agent (Fig. 4c and d). This result was subsequently validated by
incubating puriﬁed histone H3 with the recombinant PPAD, which led to histone H3
citrullination, as shown by Western blotting and mass spectrometry (Fig. 5a and b and
S3a and b). Compared to the puriﬁed human peptidylarginine deiminase 2 (PAD2),
Stobernack et al. ®













FIG 4 PPAD impacts on histone H3 citrullination and allows P. gingivalis to evade and survive capture
in neutrophil extracellular traps (NETs). (a to d) Representative ﬂuorescence microscopy images of
NETosis and citrullinated histone H3 levels in the presence of P. gingivalis. PMA was applied at a
concentration of 20 nM to induce NETosis. DNA was stained with DAPI (blue), P. gingivalis was labeled
with FITC (green), and citrullinated histone H3 (citH3; red) was visualized with a speciﬁc antibody (scale
bars, 200 m in regular images and 50 m in enlarged images). (e) Quantiﬁcation of live bacteria present
in isolated NETs.
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PPAD showed a somewhat lower citrullinating activity on puriﬁed histone H3 that
correlated with the citrullination of only one arginine residue (Arg73), whereas human
PAD2 was capable of citrullinating up to nine different arginine residues in histone H3
(Fig. 5a). Even so, in terms of citrullination of the NET-associated histone H3, the impact
of PPAD was much higher than that of any other human PAD released by neutrophils
undergoing NETosis (Fig. 4b and d). These ﬁndings are fully consistent with the
previously published observation that citrullinated histone H3 is abundantly detectable
in inﬂamed periodontal tissue (28). Thus, P. gingivalis is capable of neutralizing a major
NET-associated histone implicated in bacterial elimination in the periodontium, where
PPAD is clearly detectable (Fig. 1b).
PPAD citrullinates human lysozyme-derived peptide LP9, neutralizing its an-
tibacterial activity. The bacterial cell wall-degrading enzyme lysozyme is an important
contributor to human innate immunity. This enzyme, abundantly present in our saliva,
is also produced by neutrophils (29, 30). It acts in two different modes, the ﬁrst that the
full-size protein has muramidase activity that degrades peptidoglycan, leading to
bacterial lysis. In addition, degradation products of lysozyme act as cationic antimicro-
bial peptides (CAMPs), as was shown for the LP9 peptide (107RAWVAWRNR115) (31). LP9
introduces pores into the bacterial cell membrane by electrostatic interaction, leading
to bacterial death. Presumably, this relates to LP9’s three arginine residues. We there-
fore tested whether PPAD can neutralize LP9 by citrullination, thereby abrogating its
bactericidal activity toward LP9-susceptible bacteria. This is indeed the case, as mass
spectrometry showed that PPAD can convert all three arginines of LP9 to citrulline
(Fig. 6a). Concomitantly, citrullination reduced the bactericidal activity of LP9, as
demonstrated with the LP9-susceptible indicator Bacillus subtilis (Fig. 6b). This shows
that PPAD can even neutralize CAMPs, which belong to our most effective defenses
against bacterial pathogens. Notably, PPAD-proﬁcient and PPAD-deﬁcient P. gingivalis
strains are not susceptible to LP9 (Fig. S4). This shows that PPAD is not the only factor
that protects P. gingivalis against LP9 activity. In fact, this ﬁnding is in agreement with
the previous observation that gingipains play an important role in the deactivation of
CAMPs by proteolytic degradation (32, 33).
FIG 5 PPAD citrullinates histone H3. In vitro citrullination of histone H3. Citrullination by human PAD2
was used as a positive control. (a) Schematic representation of citrullinated arginine residues in histone
H3 upon incubation with PPAD or PAD2, as determined by mass spectrometry. (b) Western blot analysis
of citrullinated histone H3. Quantiﬁcation of band intensity in three independent experiments is shown.
*, P 0.05; ***, P 0.001, two-tailed unpaired Student’s t tests. Data are presented as mean values SD.
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PPAD is a critical virulence factor of P. gingivalis. While the above-mentioned
studies show that PPAD targets innate immunity at three different levels, an important
question that remained to be addressed was whether it contributes in vivo to the
virulence of P. gingivalis. This was investigated using larvae of the wax moth Galleria
mellonella, because this infection model only possesses an innate immune system.
Hemocytes, the main innate immune cells of G. mellonella, closely resemble human
neutrophils, since they employ the same defense mechanisms, in particular, phagocy-
tosis and NETosis (34). As shown in Fig. 7, G. mellonella larvae are less susceptible to
injected PPAD-deﬁcient P. gingivalis than to the wild-type bacteria, whereas heat-killed
P. gingivalis bacteria do not affect larval viability. This observation is fully in line with the
here-proposed role of PPAD as an immune evasion factor.
Conclusion. Altogether, our present ﬁndings show for the ﬁrst time that the
virulence factor PPAD of the oral pathogen P. gingivalis defuses antibacterial neutrophil
insults at three distinct levels, namely, phagocytosis, NETosis, and CAMP activity. This
identiﬁes PPAD as a major agent in the evasion of human innate immunity, a view that
is supported by studies from Potempa and coworkers showing PPAD-dependent
citrullination of the complement system (35). Importantly, an essential role of PPAD in
immune evasion explains why this enzyme is invariantly produced by all of the over 100
clinical isolates of P. gingivalis investigated to date (8, 36).
MATERIALS AND METHODS
Immunohistochemistry. Immunohistochemical staining of PPAD was performed as described be-
fore (28). Brieﬂy, human parafﬁn-embedded gingival tissues were collected from P. gingivalis-colonized
periodontitis patients at the dentistry department of the University Medical Center Groningen. Depar-
afﬁnization of 5-m sections was performed by several xylene, ethanol, and water washes. Endogenous
peroxidase activity was inhibited by the addition of hydrogen peroxide in methanol, followed by
FIG 6 PPAD citrullinates human lysozyme-derived peptide LP9, neutralizing its antibacterial activity.
(a) Arginine residues in the LP9 peptide (RAWVAWRNR) are citrullinated by PPAD, as determined by
mass spectrometry. Blue, red, and brown rectangles mark the outcomes from three distinct analytical
approaches, tryptic digest, C4 exclusion ﬁltration, and C18 inclusion ﬁltration, respectively. (b)
Citrullination of LP9 by PPAD or PAD2 impairs the antibacterial activity of LP9. Citrullinated LP9
exhibits signiﬁcantly reduced growth inhibition of the indicator bacterium B. subtilis. Results are
representative of three independent experiments, with three technical replicates per experiment.
OD600, optical density at 600 nm.
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blocking of nonspeciﬁc antibody binding with 1% bovine serum albumin and 1% normal goat serum in
phosphate-buffered saline (PBS). Next, samples were stained either with an in-house-produced PPAD-
speciﬁc antibody (7, 8) or with the respective preimmune serum (1:100 in PBS, 1 h). Upon removal of
excessive primary antibody by PBS, a secondary goat anti-rabbit IgG horseradish peroxidase (HRP)
antibody (P0448; Dako, Santa Clara, CA, USA) was added at a concentration of 1:100 in PBS for 45 min,
followed by washing and a developing reaction using a 3,3=-diaminobenzidine (DAB) kit (K3467; Dako).
Sections were counterstained with hematoxylin and mounted with glycerine before microscopic evalu-
ation.
P. gingivalis culture. The P. gingivalis reference strain W83 and the respective PPAD-deﬁcient mutant
(W83 ΔPPAD) (37) were grown as described before (6). For infection experiments, liquid cultures were
grown until stationary phase, which was reached after 24 h. For several experiments, inoculation was
performed by diluting bacterial glycerol stocks stored at 80°C in a 1:100 ratio into fresh brain heart
infusion (BHI) medium (Oxoid, Basingstoke, UK).
Neutrophil isolation. Neutrophils were freshly isolated from four healthy donors (two females age
27 and 34 years and two males age 28 and 39 years) who had been medically examined. Lymphoprep
buffer (StemCell Technologies, Vancouver, Canada) was used to separate cell types. EDTA-blood was ﬁrst
diluted 1:1 with PBS and then put gently on top of a volume of Lymphoprep (blood-to-Lymphoprep ratio,
2:1). Samples were centrifuged at 2,500 rpm at room temperature (RT) for 20 min without brake so as not
to disrupt the separated cell layers. The plasma, Lymphoprep, and peripheral blood mononuclear cells
were removed, and a layer of erythrocytes and neutrophils remained. The erythrocytes in this mixture
were lysed by adding ammonium chloride 0.8% and 1 mM EDTA (pH 7.4) and shaking for 10 min on ice.
After another centrifugation at 2,500 rpm for 3 min, the lysed erythrocytes were removed. These two
steps were repeated once more to obtain a pellet of puriﬁed neutrophils.
OMV and PPAD preparation. P. gingivalis cultures in late-exponential phase were used for OMV
collection. A ﬁrst centrifugation step at 8,000  g and 4°C for 20 min was performed to separate cells
from OMV-containing supernatant. The supernatant was subjected to ultracentrifugation at 100,000  g
and 4°C for 3 h in an Optima MAX-XP ultracentrifuge 261 (Beckman Coulter, Brea, CA, USA) using an
MLA-80 ﬁxed-angle rotor. The pellet containing the OMVs was resuspended in PBS, and aliquots were
frozen at 80°C before use. Protein quantiﬁcation was performed using a bicinchoninic acid (BCA)
protein assay (Pierce, Waltham, MA, USA), according to the manufacturer’s instructions, with the addition
of 2.0% SDS to solubilize proteins. Sixteen micrograms of protein was used for the phagocytosis rescue
experiment. Protein precipitation with 10% tricarboxylic acid (TCA) was performed as described before
(6) to concentrate vesicles for Western blot analysis. Recombinant PPAD was puriﬁed from Lactococcus
lactis, as previously described (7, 8).
Neutrophil infections. For neutrophil infection experiments followed by Western blotting or mass
spectrometry analyses, 3  106 neutrophils in 2.5 ml of RPMI 1640 medium (Gibco, Waltham, MA, USA)
FIG 7 PPAD is a critical virulence factor of P. gingivalis. Viability of Galleria mellonella larvae was
measured 24 h and 48 h after infection with P. gingivalis. (a) The larvae were signiﬁcantly less susceptible
to P. gingivalisW83 ΔPPAD than to the wild-type strain W83. Heat-killed bacteria were used as a negative
control. Data are means of three biological replicates (n  15). (b and c) Representative images of G.
mellonella larvae infected with P. gingivalis W83 (b) or W83 ΔPPAD (c) *, P  0.05, two-tailed unpaired
Student’s t tests.
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with 2 mM L-glutamine and 10% autologous donor serum were seeded in each well of a 6-well plate.
Phagocytosis experiments were carried out with 5  105 neutrophils in 500 l of medium in 24-well
plates. The neutrophils were allowed to rest on the plate at 37°C and 5% CO2 for 1 h. When required, 100
l supernatant of W83, 100 l BHI medium, 2.5 g recombinant PPAD, 16 g OMVs of W83, or 100 l
PBS were added to the neutrophil suspension, and incubation was continued for 30 min. Subsequently,
P. gingivalis was added at a multiplicity of infection (MOI) of 100. The neutrophils were exposed to the
bacteria for 90 min. Extracellular bacteria were then removed, and the neutrophil layer was washed once
with PBS before the addition of NP-40 lysis buffer (150 mM sodium chloride, 1.0% NP-40, 50 mM Tris [pH
8.0]) with cOmplete mini protease inhibitor (Roche, Basel, Switzerland).
Phagocytosis assay. To determine whether PPAD impacts the association and/or internalization of
P. gingivalis in neutrophils as deﬁned by Lei et al. (38), a ﬂow cytometry-based method was used as
described previously (39). Brieﬂy, a liquid bacterial culture was centrifuged for 10 min at 7,000  g and
4°C and washed once in PBS before resuspending the bacterial pellet in 0.5 M NaHCO3 (pH 8.0) to a
concentration of 2.5  109 CFU/ml before the addition of ﬂuorescein isothiocyanate (FITC; Invitrogen,
Carlsbad, USA). Bacterial concentrations were approximated by optical density readings at 600 nm
according to a standard curve for each strain used.
An FITC concentration of 0.15 mg/ml was used for staining P. gingivalisW83 and W83 ΔPPAD (39, 40).
The tubes with bacteria and FITC were subsequently incubated in the dark for 30 min at RT in a tube
rotator. The bacteria were pelleted at 7,000  g for 5 min, and the pellet was washed 3 times with PBS
to remove unbound FITC. Finally, the bacteria were resuspended to the desired concentration in RPMI
1640–10% autologous donor serum–2mM L-glutamine.
To measure the bacterial internalization rate, the extracellular ﬂuorescence (representing associated
but not internalized bacteria) was quenched using 0.2% trypan blue (Thermo Fisher Scientiﬁc, Waltham,
MA, USA). Subsequently, two washing steps with PBS were performed to remove excessive trypan blue.
Both quenched and nonquenched cell samples were ﬁxed with 4% paraformaldehyde (PFA; Sigma-
Aldrich, St. Louis, MO, USA) for 15 min prior to ﬂow cytometric analyses and visualization by ﬂuorescence
microscopy.
An Accuri C6 ﬂow cytometer was used to measure the mean ﬂuorescence intensity (MFI) of the
FITC-positive cells. The gating strategy to include only neutrophils in our analysis is shown in Fig. S1e to
g. FITC-positive cells were identiﬁed by setting a ﬂuorescence threshold in an uninfected neutrophil
control sample, next to the autoﬂuorescence peak, as shown in Fig. S1h to j. The association index of
each P. gingivalis strain was calculated by multiplying the percentage of FITC-positive cells with
associated bacteria (i.e. intracellular plus extracellularly bound bacteria) with the MFI of these cells,
divided by 100, as previously described (41). The internalization index of each P. gingivalis strain was
calculated by multiplying the percentage of cells with internalized bacteria (cells positive for FITC after
trypan blue quenching) with the MFI of these cells, divided by 100 (38). For microscopic analyses, 10 l
of the ﬁxed cells was mounted on microscopy slides and visualized with an Axio Observer.Z1 ﬂuores-
cence microscope (Zeiss, Jena, Germany) using 40 or 65 magniﬁcation. Images were recorded using
an Axio Cam MRm Rev. 3 camera with FireWire.
LDS-PAGE. Lithium dodecyl sulfate (LDS)-PAGE was performed using 10% NuPAGE gels (Invitrogen,
Carlsbad, CA, USA). Protein concentrations of cell lysates were determined with the Pierce BCA protein
assay kit (Thermo Fisher Scientiﬁc, Waltham, MA, USA) and frozen at 20°C until further use. Equal
amounts of protein samples were incubated with LDS sample buffer for 10 min at 95°C, separated by
LDS-PAGE, and either stained with SimplyBlue SafeStain (Life Technologies, Carlsbad, CA, USA) or
processed further for Western blotting.
Western blotting. For Western blotting, proteins were transferred from the gel to a nitrocellulose
membrane (Whatman, Buckinghamshire, UK) by semidry blotting. The transfer was performed at 200 mA
for 75 min in the presence of methanol-containing buffers. Upon transfer, the nonspeciﬁc binding was
blocked overnight at 4°C with 5% skim milk (Oxoid, Basingstoke, UK) in PBS. Afterwards, the blot was
rinsed once with PBS-Tween 20 (PBS-T) to remove residual skim milk. Primary rabbit anti-RgpA/B, rabbit
anti-PPAD antibodies (7, 8) or anti-histone H3 (ab18521; Abcam) in PBS-T (1:2,000) were added, and the
blot was incubated for 1 h at RT. After removing the nonbound primary antibodies by 4 washes with
PBS-T, the blot was incubated with IRDye 800CW goat anti-rabbit antibody (LI-COR Biosciences, Lincoln,
NE, USA) in PBS-T (1:10,000) protected from light for 45 min. Last, background was reduced by washing
4 times with PBS-T and subsequently washing twice with PBS to remove the Tween. Fluorescence was
measured with the LI-COR Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, USA) and
subsequently quantiﬁed using ImageJ (National Institutes of Health, Bethesda, MD, USA).
Protease activity assay. P. gingivalis was grown in BHI medium until stationary phase, and the
growth medium was separated from the cells by centriguation at 7,000  g for 10 min. Recombinant
human histone H3 (0.5 g; New England BioLabs, Ipswich, MA, USA) was incubated with 7.5 l of the
growth medium fraction for 1, 5, 10, 15, 20, and 30 min at 37°C. Fresh BHI medium (7.5 l) was used as
a negative control. The resulting protein samples were analyzed by Western blotting, as described above.
Mass spectrometry of neutrophils. Neutrophil lysates were processed for mass spectrometry
analysis, as described before (42). Brieﬂy, proteins were bound to StrataClean resins (Agilent Technolo-
gies, Santa Clara, CA, USA) and subsequently alkylated, reduced, and digested by trypsin. The resulting
peptides were puriﬁed by C18 stage-tip puriﬁcation (Thermo Fisher Scientiﬁc, Waltham, MA, USA),
according to the manufacturer’s protocol, and dried until further use.
Puriﬁed peptides were analyzed by reversed-phase liquid chromatography (LC) electrospray
ionization-tandem mass spectrometry (ESI-MS/MS) using an Orbitrap Elite mass spectrometer (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). In brief, in-house self-packed nano-LC columns (20 cm) were used
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to perform LC with an EASY-nLC 1200 system (Thermo Fisher Scientiﬁc). The peptides were loaded with
buffer A (0.1% [vol/vol] acetic acid) and subsequently eluted in 156 min using a 1% to 99% nonlinear
gradient with buffer B (0.1% [vol/vol] acetic acid, 94.9% acetonitrile). After injection into the MS, a full
scan was recorded in the Orbitrap MS with a resolution of 60,000. The 20 most abundant precursor ions
were consecutively isolated in the linear ion trap and fragmented via collision-induced dissociation (CID).
Unassigned charge states as well as singly charged ions were rejected, and the lock mass option was
enabled.
Database searching was done with Sorcerer-Sequest 4 (Sage-N Research, Milpitas, CA, USA). After
extraction from the raw ﬁles, *.dta ﬁles were searched with Sequest against a target-decoy database with
a set of common laboratory contaminants. A database for the respective peptide/protein search was
created from the published genome sequences of the W83 strain and the human genome, which were
downloaded from UniProt (http://www.uniprot.org) on 14 July 2016. The created database contained a
total of 148,472 proteins. Database search was based on a strict trypsin digestion with two missed
cleavages permitted. No ﬁxed modiﬁcations were considered. Oxidation of methionine, carbamidom-
ethylation of cysteine, and citrullination of arginine were considered variable modiﬁcations. The mass
tolerance for precursor ions was set to 10 ppm and the mass tolerance for fragment ions to 1 Da.
Validation of MS/MS-based peptide and protein identiﬁcation was performed with Scaffold version 4
(Proteome Software, Portland, OR, USA). A false-discovery rate (FDR) of 0.1% was set for ﬁltering the data.
Protein identiﬁcations were accepted if at least 2 identiﬁed peptides were detected with the above-
mentioned ﬁlter criteria in 2 out of 3 biological replicates. Protein data were exported from Scaffold and
further curated in Microsoft Excel 2013 before further analysis.
Quantitative values of protein abundances in neutrophil samples were obtained by summing up all
spectra associated with a speciﬁc protein within a sample, which includes also those spectra that are
shared with other proteins. To allow comparisons, spectral counts were normalized by applying a scaling
factor for each sample to each protein adjusting the values to normalized quantitative values.
Mass spectrometry of histone H3 and LP9. Recombinant human histone H3 (0.5 g; New England
BioLabs, Ipswich, MA, USA) was incubated with recombinant PPAD (0.25 g) overnight at 37°C. Proteins
were separated by LDS-PAGE and stained with SimplyBlue SafeStain, as described above. Histone
H3-corresponding bands (Fig. S3b) were excised from the gel, dried, and further processed by trypsin
digestion as described above.
LP9 was synthesized at EMC microcollections GmbH (Tübingen, Germany). The LP9 peptide (0.5 g)
was incubated with recombinant PPAD (0.25 g) overnight at 37°C. Subsequently, the samples were
processed by three different methods, as follows: (i) trypsin digestion, in which samples were alkylated,
reduced, digested by trypsin, and puriﬁed by C18 ZipTip puriﬁcation, as described above; (ii) C4 Exclusion
of PPAD by C4 ZipTip ﬁltration using a slight modiﬁcation of the manufacturer’s protocol, where upon
binding of PPAD to the ZipTip, the PPAD-containing tip was discarded and the LP9-containing ﬂow-
through was further processed by C18 ZipTip ﬁltration; and (iii) C18 inclusion of LP9, where the LP9
peptides were immediately puriﬁed by C18 ZipTip ﬁltration following the manufacturer’s protocol.
Puriﬁed peptides were analyzed by reversed-phase LC-ESI-MS/MS using an Orbitrap Elite spectrom-
eter (Thermo Fisher Scientiﬁc, Waltham, MA, USA). In brief, in-house self-packed nano-LC columns (20 cm;
packed with Aeris peptide material, 3.6-m XB-C18-100Å) were used to perform LC with an Easy-nLC 1200
system (Thermo Fisher Scientiﬁc). The peptides were loaded with buffer A (0.1% [vol/vol] acetic acid) and
subsequently eluted in 80 min using a nonlinear gradient of 1% to 99% with buffer B (0.1% [vol/vol]
acetic acid, 94.9% acetonitrile). After injection into the MS, a full scan was recorded in the Orbitrap
spectrometer with a resolution of 60,000. The 20 most abundant precursor ions were consecutively
isolated in the linear ion trap and fragmented via CID. Unassigned charge states and singly charged ions
were rejected, and the lock mass option was enabled.
Database searching for the histone H3 and LP9 analyses was done with Sorcerer-Sequest 4 (Sage-N
Research, Milpitas, CA, USA). After extraction from the raw ﬁles, *.dta ﬁles were searched with Sequest
against a target-decoy database with a set of common laboratory contaminants. For the peptide/protein
search, the sequence of LP9 was added to the database that was used for analysis of the neutrophil MS
data, and the database search was performed based on the same criteria as described above. For the
histone H3 analysis, Sequest identiﬁcations required XCorr scores of greater than 2.2, 3.3, and 3.8 for
doubly, triply, and all higher-charged peptides, respectively. For the LP9 analysis, Sequest identiﬁcations
required XCorr scores of greater than 2.7, 3.5, and 3.5 for doubly, triply, and all higher-charged peptides,
respectively. Protein data were exported from Scaffold. Spectra and fragmentation tables of the peptides
identiﬁed to be citrullinated are presented in Fig. S5.
Immunoﬂuorescence microscopy of NET formation. For microscopic analysis of infected neutro-
phils, sterile 12-mm-diameter coverslips (Menzel-Gläser, Braunschweig, Germany) were placed into
24-well plates (Corning, Corning, NY, USA). A total of 2.5  105 neutrophils in 500 l RPMI 1640 medium
were added to each well. To let the neutrophils adhere to the coverslips, plates were incubated for 1 h
at 37°C and 5% CO2. Subsequently, cells were stimulated for 1 h with 20 mM phorbol myristate acetate
(PMA; Sigma-Aldrich, St. Louis, MO, USA) to induce NETosis and then infected with P. gingivalis at an MOI
of 100 for 90 min. Upon infection, 500 l of 8% PFA was added to each well to reach a ﬁnal concentration
of 4% PFA to ﬁx the cells. Plates were stored at 4°C in the dark, and immunoﬂuorescence staining was
performed on the following day. For this, the ﬁxative solution was removed, and the cell layer was
washed carefully one time with PBS. A blocking step was performed by incubating cells at room
temperature (RT) with 2% bovine serum albumin (BSA) in PBS for 1 h. Citrullinated histone H3 in NETs was
stained with a rabbit anti-citrullinated histone H3 antibody (ab5103, 1:250; Abcam) and incubated for 1 h
at RT in PBS, 0.05% Tween 20, and 0.5% BSA. Coverslips were washed with PBS before adding secondary
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antibodies. The Alexa Fluor 568 goat anti-rabbit antibody (catalog no. A11011, 1:400; Invitrogen) was
used to visualize the primary antibodies. Secondary antibodies were added in PBS with 4=,6-diamidino-
phenylindole (DAPI; product no. 10236276001, 1:5,000; Roche) and incubated for 30 min before mount-
ing the coverslips in citiﬂuor (CitiFluor, Hatﬁeld, PA, USA). Slides were then analyzed using a Leica DFC450
C ﬂuorescence microscope with the Leica Application Suite software version 4.2.0.
NET survival assay. NETosis was induced, and P. gingivalis was added to the NETs as described
above, with the modiﬁcation that no coverslips were placed into the wells. Upon 90 min of infection,
NETs were isolated as described previously (43). Subsequently, different dilutions of bacteria trapped in
the NETs were plated on blood agar base no. 2 (BA2) plates (Oxoid, Basingstoke, UK). The plates were
incubated for 5 days at 37°C under anaerobic conditions, and P. gingivalis colonies were counted.
Citrullination of LP9 and killing assay. Bacillus subtilis strain 168 was grown overnight in BHI broth
(Oxoid, Basingstoke, UK) with shaking at 37°C. The culture was diluted to an optical density at 600 nm
of 0.1, and 100 l of this suspension was pipetted in each well of a 96-well plate. Bacteria were grown
for 2 h shaking at 37°C in a Biotek Synergy 2 microplate reader (Biotek Instruments, Inc., Winooski, VT,
USA) until they reached exponential phase, and LP9 (in PBS) was added at a ﬁnal concentration of
200 g/ml. To investigate the effect of citrullination on its activity, LP9 was preincubated with PPAD or
human peptidylarginine deiminase 2 (hPAD2) overnight at 37°C before its addition. Bacterial growth was
monitored until stationary phase, and the respective growth curves were plotted with GraphPad Prism
version 6 (GraphPad Software, La Jolla, CA, USA). The effect of LP9 on exponentially growing cells was
determined by measuring the growth delay of B. subtilis upon the addition of LP9. The same procedure
was applied for the killing assay of P. gingivalis. However, for P. gingivalis, standing cultures were grown
for 48 h at 37°C.
In vivo Galleria mellonella survival assay. Larvae of G. mellonella were injected with the P. gingivalis
W83 strain or the respective PPAD-deﬁcient mutant. Bacteria were injected into the last proleg at a
volume of 10 l using a HumaPen Luxura HD pen (Eli Lilly, Indianapolis, IN, USA). Viability was scored by
one trained person at 24 h and 48 h postinfection based on pigmentation and mobility. To assess the
virulence of the investigated P. gingivalis strains, the larvae were infected with 108 PBS-washed bacteria.
Heat-killed bacteria (30 min, 90°C) were used as a negative control.
Statistical analyses. Statistical analyses were performed with GraphPad Prism version 6 (GraphPad
Software, La Jolla, CA, USA) or with Scaffold version 4 (Proteome Software, Portland, OR, USA). Two
groups were compared by performing an unpaired two-tailed Student’s t test. Fisher’s exact test was
used to assess the signiﬁcance of differences in normalized spectral counts of neutrophil proteins
detected by MS. Signiﬁcance was deﬁned as a P value lower than or equal to 0.05.
Medical ethics committee approval. Blood donations from healthy volunteers were collected with
approval of the medical ethics committee of the University Medical Center Groningen (UMCG; approval
no. Metc2012-375). All blood donations were obtained after written informed consent from all volunteers
and adhering to the Declaration of Helsinki guidelines.
Biological and chemical safety. P. gingivalis was handled following appropriate safety and con-
tainment procedures for biosafety level 2 microbiological agents. All experiments involving human cells
were performed under appropriate safety conditions. All chemicals and reagents applied in this study
were handled according to local guidelines for safe usage and protection of the environment.
Data availability. The mass spectrometry data are deposited in the ProteomeXchange repository
PRIDE: https://www.ebi.ac.uk/pride/archive/projects/PXD010798 (neutrophil infection) and https://www
.ebi.ac.uk/pride/archive/projects/PXD009081 (histone H3 and LP9).
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